Fusion event
HBV-CLPTM1L integration
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Normal
Integrated sequence
CAATGTCAACGACCGACCTTGAGGCATACTTCAAAGACTGTTTGTTTAAAGACTGGGAGGAGTTGGGGGAGGAGATTAGGTTAAAGGTCTTTGTACTAGG| |AGGCTGTAGGCATAAATTGGTCTGCGCACCAGCACCATGCAACTTTTTCACCTCTGCCTAATCATCTCTTGTTCATGTCCTACTGTTCAAGCCTCCAAGC
End
1333643/1333528 (Hg38)
miRNAs that regulate target gene
Nearest miRNA
hsa-mir-4457/Upstream/24151; hsa-mir-10397/Downstream/177234;
Upstream sequence
GCTATGTCACTTGAATCTCATGTGATCTATTTGTTATttttttattttttattatactttttaagttttagggtacatgtgcacaacgtgcaggttagtt
Downstream sequence
GAGGATAAGGGGGGACTACTGTATACACACCGGATGAGGATAAGGGGAGACTACTGTATACACACGGGATGAGGATGAGGGACTATTGTATACACACCAG
Yang, L., et al. Molecular Characterization of HBV DNA Integration in Patients with Hepatitis and Hepatocellular Carcinoma. J Cancer ,2018,9(18): 3225-3235.